[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" z_index=""][vc_column][vc_column_text css=".vc_custom_1744246567177{padding-bottom: 32px !important;}"]Recent regulatory changes have simplified the process for importing cannabis-derived active pharmaceutical ingredients (APIs), such as CBD Isolate, into the Brazilian market. These adjustments reflect a shift in Brazil’s approach, aligning more closely with...

Vantage Hemp's EP cGMP CBD Isolate Meets the Specifications of European Pharmacopoeia Monograph 07/2024:3151 for Cannabidiol (CBD). The European Pharmacopoeia (Ph. Eur.) has recently published new monographs, including one specifically for Cannabidiol (CBD). This monograph, published in Supplement 11.5 of the Ph. Eur., became effective in...

In Australia, recent updates to cannabis laws reflect ongoing efforts to ensure the quality and safety of medicinal cannabis products. The Therapeutic Goods Administration (TGA) has mandated that both domestically produced and imported medicinal cannabis must adhere to strict GMP standards, aligning them with the...